Paediatric consumer health is expected to see a slightly slower current value growth rate in 2020 than was seen in 2019. Paediatric vitamins and dietary supplements will remain by far the largest category within paediatric consumer health, as parents want to support their children’s growth and development despite its growth rate expected to be only slightly higher in 2020 than in the previous year and it being the highest growth category.
The retail value growth rate of paediatric analgesics is rising in 2020, albeit at a slower rate than in 2019, especially for the relief of fever. Parents are eager to ease their children's condition when they are sick, and often it is the fever that is treated more than the cold as cough, cold and allergy remedies for children are normally not as popular, although 2020 is an exception due to the pandemic.
Teva Pharmaceutical Industries is the leader in paediatric consumer health in 2020. The company ended its joint venture with Procter & Gamble, PGT Healthcare, in April 2018 and reclaimed its OTC portfolio; therefore, after several years of PGT Healthcare holding top spot in paediatric consumer health, Teva Pharmaceutical Industries regained prominence in the category in 2018 and retained its lead in 2019.
Paediatric consumer health is forecast to maintain the slightly slower constant value growth rate expected in 2020 throughout the forecast period, with the forecast constant value CAGR set to be lower than that seen in the review period. Paediatric vitamins and dietary supplements is expected to see the highest constant retail value growth rate over the forecast period and to retain its overall dominance within paediatric consumer health, as Israeli parents are increasingly likely to purchase these products for their children.
Paediatric vitamins and dietary supplements is expected to continue its strong retail value growth in the forecast period at constant 2020 prices, mainly due to the hectic lifestyles of Israeli families. Parents work long hours and children spend many hours of the day in school or kindergarten or at after-school activities.
Several paediatric cough/cold remedies were taken off the shelves during the review period after the Ministry of Health banned the use of pseudoephedrine in combination with other components in paediatric remedies. These have not been replaced by other, pseudoephedrine-free versions; they simply disappeared from store shelves.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Paediatric consumer health industry in Israel with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Paediatric consumer health industry in Israel, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Paediatric consumer health research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page